MP43-09 RISK OF ADVERSE PATHOLOGY AFTER DEFERRED PROSTATECTOMY FOR GRADE GROUP 1 AND 2 PROSTATE CANCER BEING MANAGED BY ACTIVE SURVEILLANCE. (1st May 2022) - Williams, Cheyenne